EWING, N.J.--(BUSINESS WIRE)--
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton,
Ph.D., President and Chief Executive Officer, will present at the Bank
of America Merrill Lynch 2014 Healthcare Conference on Wednesday May 14,
2014 at 8:40 am PDT.
A live webcast of the presentation will be available via the “Investor
Relations” page of the Antares website, www.antarespharma.com.
A replay of the webcast will also be archived on Antares’ website for 90
days following the presentation.
About Antares Pharma
Antares Pharma focuses on self-administered parenteral pharmaceutical
products and topical gel-based medicines. The Company has received
marketing approval from the U.S. Food and Drug Administration for
OTREXUP™ (methotrexate) injection for the treatment of adults with
severe active rheumatoid arthritis and children with active
polyarticular juvenile idiopathic arthritis. LEO Pharma markets OTREXUP™
to dermatologists for adults with severe recalcitrant psoriasis. Antares
Pharma is also developing VIBEX® QS T for testosterone
replacement therapy. The Company's technology platforms include VIBEX®
disposable Medi-Jet, disposable multi-use pen injectors and Vision™
reusable needle-free injectors marketed as Tjet® and Zomajet®
by Teva Pharmaceutical Industries, Ltd (Teva) and Ferring
Pharmaceuticals (Ferring), respectively. Antares Pharma has a
multi-product deal with Teva that includes Tev-Tropin®
[somatropin (rDNA origin) for injection] human growth hormone (hGH),
VIBEX® epinephrine and several other products. In the U.S.
Antares has received FDA approval for Gelnique 3%™ (oxybutynin) gel, a
treatment for overactive bladder that is marketed by Actavis. Elestrin®
(estradiol gel) is FDA approved for the treatment of moderate-to-severe
vasomotor symptoms associated with menopause, and is marketed in the
U.S. by Meda Pharma. Antares Pharma has two facilities in the U.S. The
Parenteral Products Group located in Minneapolis, Minnesota directs the
manufacturing and marketing of the Company’s reusable needle-free
injection devices and related disposables, and develops its disposable
pressure-assisted Medi-Jet and pen injector systems. The Company’s
corporate office and Product Development and Commercial Groups are
located in Ewing, New Jersey.
Antares Pharma, Inc.
Vice President, Corporate
Source: Antares Pharma, Inc.